Who owns GAIN THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Gain Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Gain Therapeutics stock

Who bought or sold GAIN THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Marshall Wace 1.9M $3.9M 9% Jun 2026
 View chart
Potomac Capital Management 946k $1.9M -6% Jun 2026
 View chart
GSA Capital Partners 632k $1.3M 102% Jun 2026
 View chart
Jones Financial Companies, L.L 609k $1.1M -4% Jun 2026
 View chart
Cambridge Investment Research Advisors 567k $980k 0% Sep 2026
 View chart
DME Capital Management 566k $1.1M 0% Jun 2026
 View chart
Vanguard Capital Management 480k $975k 20% Jun 2026
 View chart
Geode Capital Management 470k $813k 4% Sep 2026
 View chart
BlackRock 275k $558k 22% Jun 2026
 View chart
Vanguard Fiduciary Trust 232k $470k 1% Jun 2026
 View chart
UBS Group 215k $437k -2% Jun 2026
 View chart
Stratos Wealth Partners 200k $406k 52% Jun 2026
 View chart
Citadel Advisors 195k $396k 176% Jun 2026
 View chart
Cresset Asset Management 160k $325k 0% Jun 2026
 View chart
State Street Corporation 158k $320k 0% Jun 2026
 View chart
Susquehanna International 143k $290k -70% Jun 2026
 View chart
LPL Financial 117k $203k 0% Sep 2026
 View chart
Jane Street 97k $197k -62% Jun 2026
 View chart
Northern Trust 97k $197k -15% Jun 2026
 View chart
Commonwealth Equity Services 58k $100k -1% Sep 2026
 View chart
XTX Topco 55k $112k 100% Jun 2026
 View chart
Springbok Capital Management 36k $73k 0% Jun 2026
 View chart
Apollon Wealth Management 32k $55k 19% Sep 2026
 View chart
Bridgeway Capital Management 30k $61k 0% Jun 2026
 View chart
Simplex Trading 29k $49k 100% Sep 2026
 View chart
Intl Fcstone 25k $44k 100% Sep 2026
 View chart
Virtu Financial 21k $43k 97% Jun 2026
 View chart
Oliver Luxxe Assets 20k $35k 0% Sep 2026
 View chart
Bank Of Oklahoma National Association / 20k $35k 100% Sep 2026
 View chart
Vanguard Global Advisers 18k $37k 0% Jun 2026
 View chart
HighTower Advisors 17k $30k 0% Sep 2026
 View chart
Wealth Enhancement Advisory Services 17k $28k 0% Sep 2026
 View chart
Sontag Advisory 17k $34k 0% Jun 2026
 View chart
Sandhill Capital Partners 15k $31k 0% Jun 2026
 View chart
Millington Financial Advisors 15k $26k 0% Jun 2026
 View chart
Benedict Financial Advisors 14k $23k -61% Sep 2026
 View chart
HB Wealth Management 13k $22k 0% Sep 2026
 View chart
Two Sigma Securities 13k $26k 100% Jun 2026
 View chart
R Squared 12k $20k 100% Sep 2026
 View chart
Harbour Investments 11k $19k 0% Sep 2026
 View chart
Goss Wealth Management 11k $22k 0% Jun 2026
 View chart
Sanctuary Advisors 10k $20k 100% Jun 2026
 View chart
Mercer Global Advisors 10k $20k 100% Jun 2026
 View chart
Wells Fargo & Company 9.4k $19k -15% Jun 2026
 View chart
Tower Research Capital 8.3k $17k 51% Jun 2026
 View chart
Group One Trading 3.8k $7.7k -41% Jun 2026
 View chart
Advisor Group Holdings 2.0k $4.1k 100% Jun 2026
 View chart
Jpmorgan Chase & Co 1.7k $3.4k 100% Jun 2026
 View chart
SRS Capital Advisors 1.7k $3.5k 100% Jun 2026
 View chart
Caitong International Asset Management 101.00 $175.002700 -39% Sep 2026
 View chart
Larson Financial Group 10.00 $17.000000 0% Sep 2026
 View chart
Barclays 2.00 $3.000000 -100% Sep 2026
 View chart

Who sold out of Gain Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Squarepoint Ops Jun 2026 136k $277k
Schonfeld Strategic Advisors Mar 2026 25k $48k